LENZ logo

LENZ Therapeutics, Inc. (LENZ) Retained earnings

annual retained earnings:

-$145.01M-$49.77M(-52.25%)
December 31, 2024

Summary

  • As of today (September 16, 2025), LENZ annual retained earnings is -$145.01 million, with the most recent change of -$49.77 million (-52.25%) on December 31, 2024.
  • During the last 3 years, LENZ annual retained earnings has fallen by -$3.66 million (-2.59%).
  • LENZ annual retained earnings is now -6438.05% below its all-time high of -$2.22 million, reached on December 1, 2019.

Performance

LENZ Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZbalance sheet metrics

quarterly retained earnings:

-$174.54M-$14.91M(-9.34%)
June 30, 2025

Summary

  • As of today (September 16, 2025), LENZ quarterly retained earnings is -$174.54 million, with the most recent change of -$14.91 million (-9.34%) on June 30, 2025.
  • Over the past year, LENZ quarterly retained earnings has dropped by -$52.40 million (-42.90%).
  • LENZ quarterly retained earnings is now -147.26% below its all-time high of -$70.59 million, reached on December 1, 2020.

Performance

LENZ quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLENZbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

LENZ Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-52.3%-42.9%
3 y3 years-2.6%+9.6%
5 y5 years-6438.1%-

LENZ Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-52.3%+40.2%-83.3%+49.3%
5 y5-year-6438.1%+40.2%-147.3%+49.3%
alltimeall time-6438.1%+40.2%-147.3%+49.3%

LENZ Retained earnings History

DateAnnualQuarterly
Jun 2025
-
-$174.54M(+9.3%)
Mar 2025
-
-$159.63M(+10.1%)
Dec 2024
-$145.01M(+52.3%)
-$145.01M(+9.6%)
Sep 2024
-
-$132.36M(+8.4%)
Jun 2024
-
-$122.15M(+9.2%)
Mar 2024
-
-$111.89M(+17.5%)
Dec 2023
-$95.25M(-60.7%)
-$95.25M(-72.3%)
Sep 2023
-
-$344.14M(+7.0%)
Jun 2023
-
-$321.65M(+20.8%)
Mar 2023
-
-$266.34M
DateAnnualQuarterly
Dec 2022
-$242.40M(+71.5%)
-
Dec 2022
-
-$242.40M(+11.3%)
Sep 2022
-
-$217.80M(+12.8%)
Jun 2022
-
-$193.12M(+15.5%)
Mar 2022
-
-$167.19M(+18.3%)
Dec 2021
-$141.35M(+100.2%)
-$141.35M(+15.5%)
Sep 2021
-
-$122.42M(+13.5%)
Jun 2021
-
-$107.83M(+19.4%)
Mar 2021
-
-$90.30M(+27.9%)
Dec 2020
-$70.59M(+3082.6%)
-$70.59M
Dec 2019
-$2.22M
-

FAQ

  • What is LENZ Therapeutics, Inc. annual retained earnings?
  • What is the all time high annual retained earnings for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is LENZ Therapeutics, Inc. quarterly retained earnings?
  • What is the all time high quarterly retained earnings for LENZ Therapeutics, Inc.?
  • What is LENZ Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is LENZ Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of LENZ is -$145.01M

What is the all time high annual retained earnings for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high annual retained earnings is -$2.22M

What is LENZ Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, LENZ annual retained earnings has changed by -$49.77M (-52.25%)

What is LENZ Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of LENZ is -$174.54M

What is the all time high quarterly retained earnings for LENZ Therapeutics, Inc.?

LENZ Therapeutics, Inc. all-time high quarterly retained earnings is -$70.59M

What is LENZ Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, LENZ quarterly retained earnings has changed by -$52.40M (-42.90%)
On this page